GlassScriptPhysician profile
Kevin Tsai
NPI 1366830689
$13,803.37
in general payments reported to CMS, 2019-2025
42 companies · $3,539 in 2025
The $3,539 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $187 · 2021: $1,229 · 2022: $2,167 · 2023: $3,044 · 2024: $3,207 · 2025: $3,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,490 · Travel and Lodging: $1,073 · Education: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,489.67 |
| Travel and Lodging | $1,073.43 |
| Education | $227.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,186.18 | 2021-2025 | Linq II, Onyx Frontier, Symplicity G3 |
| Astrazeneca Pharmaceuticals LP | $1,657.03 | 2019-2025 | Farxiga |
| Boston Scientific Corporation | $1,345.44 | 2021-2025 | Farapulse, Versacross Access Solution, Watchman Flx |
| Shockwave Medical, INC | $920.70 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $887.48 | 2021-2025 | Aveir, Diamondback Peripheral, Cardiomems |
| Janssen Pharmaceuticals, INC | $838.19 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $569.54 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $553.91 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $515.47 | 2022-2025 | Amvuttra |
| Amgen INC. | $511.71 | 2019-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $381.15 | 2022-2025 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $360.21 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $251.22 | 2021-2022 | |
| Cardiva Medical, INC. | $226.49 | 2019-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Asahi Intecc USA, INC. | $218.27 | 2023 | Asahi Ptca Guide Wire |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $207.88 | 2023-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $202.56 | 2020-2025 | |
| Bridgebio Pharma, INC. | $187.43 | 2025 | Attruby |
| Pfizer INC. | $185.32 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $174.12 | 2022-2023 | |
| Novo Nordisk INC | $150.66 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $138.67 | 2024-2025 | Verquvo, Capvaxive |
| Kestra Medical Technology Services, INC. | $132.22 | 2025 | Assure Wcd |
| Terumo Medical Corporation | $129.09 | 2022-2025 | Tr Band, Heartrail, Glidesheath Slender |
| Astellas Pharma US INC | $118.07 | 2020-2021 | |
| Inari Medical, INC. | $114.47 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Xeris Pharmaceuticals, INC. | $111.15 | 2025 | Recorlev |
| Scpharmaceuticals INC. | $83.56 | 2025 | |
| Cardiovascular Systems INC. | $83.22 | 2022-2023 | Diamondback Peripheral |
| Avanos Medical | $55.55 | 2024 | Pnb and Accessories |
| Medicomp INC | $37.54 | 2025 | Telepatch Cardiac Monitor |
| Becton, Dickinson and Company | $37.34 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.67 | 2019 | |
| Heartflow, INC. | $32.32 | 2025 | |
| Chiesi USA, INC. | $29.69 | 2020-2023 | Kengreal |
| Daiichi Sankyo INC. | $28.16 | 2022 | |
| Lantheus Medical Imaging, INC. | $20.84 | 2023 | Definity |
| Aurinia Pharma U.S., INC. | $19.96 | 2023 | |
| Lilly USA, LLC | $18.65 | 2025 | Zepbound, Mounjaro |
| Altathera Pharmaceuticals LLC | $17.04 | 2025 | Sotalol Hydrochloride |
| Biosense Webster, INC. | $16.70 | 2022 | |
| Stryker Corporation | $15.50 | 2023 | N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.